RxDoctor Payments DataLook up a doctor →

Anthony Delsignore, MD

Otolaryngology · New York, NYNPI 1548420847

Payments from drug & device makers

$965,582in general payments, 2019–2025

Across 305 payments — averaging $3165.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$462K
  • Stryker$353K
  • Aerin Medical Inc.$60K
  • Neurent Medical Limited$46K
  • Sanofi$19K
  • Arrinex, Inc.$15K
  • plus $11K from 10 others
$56,874in research payments, 2019–2025

Across 9 payments — averaging $6319.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurent Medical Limited$57K

What the payments were for

  • Consulting fees$56,42864%
  • Speaking & faculty fees$1,0401%
  • Travel & lodging$14,47016%
  • Food & beverage$16,73519%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$965,582 in reported general payments places this provider in the 95th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$83,255
Medicare patients
145
Services billed
524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl861$13,237
Budesonide29$4,164
Ipratropium Bromide109$2,334
Mupirocin158$1,443
Fluticasone Propionate129$1,031
Levocetirizine Dihydrochloride75$600
Doxycycline Hyclate23$173
Methylprednisolone19$148
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$105
Montelukast Sodium18$104
Prednisone14$49
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$26

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →